101 related articles for article (PubMed ID: 15760554)
21. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
[TBL] [Abstract][Full Text] [Related]
22. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
23. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
24. Effect of transcatheter arterial chemoembolization on cellular immune function and regulatory T cells in patients with hepatocellular carcinoma.
Liao J; Xiao J; Zhou Y; Liu Z; Wang C
Mol Med Rep; 2015 Oct; 12(4):6065-71. PubMed ID: 26239573
[TBL] [Abstract][Full Text] [Related]
25. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
26. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-7 enhances anti-tumor activity of CD8
Teng D; Ding L; Cai B; Luo Q; Wang H
Cytokine; 2019 Jun; 118():115-123. PubMed ID: 29655570
[TBL] [Abstract][Full Text] [Related]
28. [Changes of immune function in liver cirrhosis patients after splenectomy combined with resection of hepatocellular carcinoma].
Cao Z; Cheng X; Wu Z
Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):97-9. PubMed ID: 11955389
[TBL] [Abstract][Full Text] [Related]
29. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
[TBL] [Abstract][Full Text] [Related]
30. Observation of changes in peripheral T-lymphocyte subsets by flow cytometry in patients with liver cancer treated with radioimmunotherapy.
Zeng ZC; Tang ZY; Liu KD; Yu YQ; Yang BH; Cai XJ; Xie H; Cao SL
Nucl Med Commun; 1995 May; 16(5):378-85. PubMed ID: 7659390
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of p-STAT3 in peripheral blood CD4+ and CD8+ T cells related to hepatocellular carcinoma development.
Wang X; Xin W; Zhang H; Zhang F; Gao M; Yuan L; Xu X; Hu X; Zhao M
Mol Med Rep; 2014 Nov; 10(5):2649-56. PubMed ID: 25175640
[TBL] [Abstract][Full Text] [Related]
32. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
[TBL] [Abstract][Full Text] [Related]
33. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
Liu S; Yang L; Jia S; Zhao R; Jin Z
Int Immunopharmacol; 2021 Nov; 100():108161. PubMed ID: 34555643
[TBL] [Abstract][Full Text] [Related]
35. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
[TBL] [Abstract][Full Text] [Related]
36. [Effects of PreS2 synthetic peptides on infiltrating T lymphocyte subgroups expression in hepatocellular carcinoma].
Zheng SC; Wei XY; Xu CB; Xie HQ
Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):415-7. PubMed ID: 12890345
[TBL] [Abstract][Full Text] [Related]
37. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
[TBL] [Abstract][Full Text] [Related]
38. Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma.
Huang CY; Wang H; Liao W; Han F; Li YQ; Chen SW; Lao XM
J Immunother; 2017 Jun; 40(5):175-186. PubMed ID: 28394813
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
40. Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.
Duan Z; Gao J; Zhang L; Liang H; Huang X; Xu Q; Zhang Y; Shen T; Lu F
Oncotarget; 2015 Dec; 6(42):44239-53. PubMed ID: 26517519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
